Home
Inibsa

Inibsa Market Share Analysis for November 2025

These are some of the highlights from AEEDC.

Health > Biotechnology and Pharmaceuticals

Domaininibsa.com

Year Founded1948

Employees201 - 500

Annual Revenue$50M - $75M

Inibsa

Inibsa (including company regionals)

inibsa.com

See more website traffic and engagement information

Inibsa Revenue up to November 2025 is 50M - 75M

revenue generated by Inibsa top domains

Inibsa top domains revenue over 3 years

Revenue for Inibsa top domains

inibsa.com50M - 75M

See more with Sales Intelligence

Total visits to Inibsa's top domains

Understand Inibsa market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

inibsa.com2.8K

See more with Sales Intelligence

Avg. visit duration in Inibsa's top domains

Analyze Inibsa engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

inibsa.com00:00:46

See more with Sales Intelligence

Avg. pageviews on Inibsa's top domains

See how Inibsa keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

inibsa.com1.92

See more with Sales Intelligence

Inibsa top competitors by domain

Top similar sites in November 2025, ranked by their affinity

normon.esCompany NameNormonEmployees1001 - 5000HQSpain, Tres CantosAnnual revenue< $1MTotal visits51.9KHealth > Health - Other

Top technologies used by Inibsa

These are the website technologies, by industry, used by Inibsa top domains

Advertising (4)

DoubleClick

Social (4)

Instagram

Widget (4)

Twemoji

Audio Video Media (2)

YouTube

More Technologies

9

See all

News & Signals from Inibsa

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsActeon Group acquires Inibsa.Septodont, a leading manufacturer of dental products, and Acteon, a leading manufacturer of dental products and medical devices, finalized the acquisition of Laboratorios Inibsa, a global pharmaceutical group located in Barcelona (Spain) specializing in the development and manufacturing of products for dental practitioners and dental professionals.

NewsInibsa invested into assets: anaesthetic production line in the amount of $20.1M on Jan 1st '16.During this time, Inibsa has invested more than 19 million EUR, extended the facilities in 2015, purchased a new anaesthetic production line in 2016, and refurbished the Microbiology, Pharmaceutical Development and Physical and Chemical laboratories in the years 2017-2018, obtaining as a result state-of-the-art premises and top-of-the-line technology for the manufacture of dental anaesthetics.

NewsInibsa invested into assets: anaesthetic production line in the amount of $21.7M on Jan 1st '16.During this time, Inibsa has invested more than 19 million EUR, extended the facilities in 2015, purchased a new anaesthetic production line in 2016, and refurbished the Microbiology, Pharmaceutical Development and Physical and Chemical laboratories in the years 2017-2018, obtaining as a result state-of-the-art premises and top-of-the-line technology for the manufacture of dental anaesthetics.